Table 1.
Correlation between the results for mean QSOX1 expression and the clinical and pathological variables.
| Variable | n. | QSOX1 |
|---|---|---|
| Sex | ||
| Female | 12 | 58.38 |
| Male | 11 | 48.17 |
| Age at diagnosis | ||
| ≤18 months | 14 | 60.85 |
| >18 months | 09 | 42.07 |
| Location of the lesion | ||
| Extra- | 09 | 45.58 |
| abdominal Abdominal | 14 | 58.59 |
| Bone marrow infiltration | ||
| Negative | 11 | 54.52 |
| Positive | 04 | 48.70 |
| Differentiation of the lesion | ||
| Poorly differentiated | 09 | 43.94 |
| Well-differentiated | 14 | 59.65 |
| Shimada classification | ||
| Favourable | 18 | 57.43 |
| Unfavourable | 5 | 39.36 |
| Tumor stroma | ||
| Rich | 14 | 43.94° |
| Poor | 9 | 59.65° |
| Tumor stage | ||
| IIA | 5 | 41.43 |
| III | 2 | 52.66 |
| IV | 16 | 53.50 |
| Death | ||
| Survival 5.45 years* | 09 | 55.26 |
| Alive | ||
| Follow-up 1.3 years* | 14 | 52.36 |
| Alive with relapse/residual disease | ||
| Follow-up 3 years* | 08 | 64.79 |
| Alive without relapse/residual disease | ||
| Follow-up 3 years* | 06 | 35.81 |
Mean QSOX1 values are expressed as the mean positive staining area in µm2 per histological field.
*Follow-up time or mean survival in years for each of the clinical-course variables, i.e., whether the patient died or was alive with or without a relapse/residual disease.
°P=0.054, with a statistically significant trend.